95 related articles for article (PubMed ID: 22588782)
1. Current status of molecular biology and treatment strategy for neuroblastoma.
Mugishima H
Int J Clin Oncol; 2012 Jun; 17(3):189. PubMed ID: 22588782
[No Abstract] [Full Text] [Related]
2. Personalized medicine. Pushing the envelope in neuroblastoma therapy.
Couzin-Frankel J
Science; 2011 Sep; 333(6049):1569-71. PubMed ID: 21921174
[No Abstract] [Full Text] [Related]
3. Chemotherapy for neuroblastoma: is it all or none?
Maris JM; Castleberry RP
J Pediatr Hematol Oncol; 2003 Jul; 25(7):512-4. PubMed ID: 12847315
[No Abstract] [Full Text] [Related]
4. System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma.
Morozova O; Vojvodic M; Grinshtein N; Hansford LM; Blakely KM; Maslova A; Hirst M; Cezard T; Morin RD; Moore R; Smith KM; Miller F; Taylor P; Thiessen N; Varhol R; Zhao Y; Jones S; Moffat J; Kislinger T; Moran MF; Kaplan DR; Marra MA
Clin Cancer Res; 2010 Sep; 16(18):4572-82. PubMed ID: 20651058
[TBL] [Abstract][Full Text] [Related]
5. Possible relationship of chromosome abnormalities and gene amplification with effects of chemotherapy: a neuroblastoma xenograft study.
Tsuchida Y; Kaneko Y; Kanda N; Makino S; Utakoji T; Saito S
Prog Clin Biol Res; 1985; 175():171-80. PubMed ID: 3991730
[TBL] [Abstract][Full Text] [Related]
6. Targeting the right treatments for neuroblastoma.
Nelson NJ
J Natl Cancer Inst; 2011 Aug; 103(16):1218-21. PubMed ID: 21813407
[No Abstract] [Full Text] [Related]
7. Pharmacotherapy of neuroblastoma.
George RE; Diller L; Bernstein ML
Expert Opin Pharmacother; 2010 Jun; 11(9):1467-78. PubMed ID: 20408767
[TBL] [Abstract][Full Text] [Related]
8. Pediatric cancer genomics, a play rather than a portrait.
Ramaswamy V; Taylor MD
Nat Genet; 2015 Aug; 47(8):851-2. PubMed ID: 26220132
[TBL] [Abstract][Full Text] [Related]
9. Targeting ALK: The Ten Lives of a Tumor.
Versteeg R; George RE
Cancer Discov; 2016 Jan; 6(1):20-1. PubMed ID: 26747894
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies for the treatment of neuroblastoma.
Izbicka E; Izbicki T
Curr Opin Investig Drugs; 2005 Dec; 6(12):1200-14. PubMed ID: 16370386
[TBL] [Abstract][Full Text] [Related]
11. Targeting oncogene expression in a childhood cancer.
Tuthill MC; Wada RK
Hawaii Med J; 2003 Oct; 62(10):224-5. PubMed ID: 14631595
[No Abstract] [Full Text] [Related]
12. Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.
Pinto N; Cipkala DA; Ladd PE; Pu Y; Cohn SL
Pediatr Blood Cancer; 2014 Jun; 61(6):1104-6. PubMed ID: 24293072
[TBL] [Abstract][Full Text] [Related]
13. Aiming at neuroblastoma and hitting other worthy targets.
Schor NF
J Child Neurol; 2013 Jun; 28(6):768-73. PubMed ID: 23576410
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomas.
Oehme I; Lodrini M; Brady NR; Witt O
Autophagy; 2013 Dec; 9(12):2163-5. PubMed ID: 24145760
[TBL] [Abstract][Full Text] [Related]
15. Updates in the treatment of neuroblastoma.
Modak S
Clin Adv Hematol Oncol; 2011 Jan; 9(1):74-6. PubMed ID: 21326151
[No Abstract] [Full Text] [Related]
16. Micro-RNA-21 regulates the sensitivity to cisplatin in human neuroblastoma cells.
Chen Y; Tsai YH; Fang Y; Tseng SH
J Pediatr Surg; 2012 Oct; 47(10):1797-805. PubMed ID: 23084187
[TBL] [Abstract][Full Text] [Related]
17. The mTOR signaling pathway in pediatric neuroblastoma.
Mei H; Wang Y; Lin Z; Tong Q
Pediatr Hematol Oncol; 2013 Oct; 30(7):605-15. PubMed ID: 23697980
[TBL] [Abstract][Full Text] [Related]
18. miR-129 inhibits tumor growth and potentiates chemosensitivity of neuroblastoma by targeting MYO10.
Wang X; Li J; Xu X; Zheng J; Li Q
Biomed Pharmacother; 2018 Jul; 103():1312-1318. PubMed ID: 29864913
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma treatment in the post-genomic era.
Esposito MR; Aveic S; Seydel A; Tonini GP
J Biomed Sci; 2017 Feb; 24(1):14. PubMed ID: 28178969
[TBL] [Abstract][Full Text] [Related]
20. Dinutuximab approved for high-risk neuroblastoma.
Cancer Discov; 2015 Jun; 5(6):OF5. PubMed ID: 25851859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
